Valuation: GeneMatrix Inc.

Market Cap 39.14B 52,707B 34.77B 32.45B 29.58B 55.79B 3,762B 56.31B 393B 152B 1,923B 147B 144B 6,173B P/E 2017
-24.8x
P/E 2018 -20.9x
Enterprise Value 41.07B 55,311B 36.49B 34.06B 31.04B 58.55B 3,948B 59.09B 412B 160B 2,018B 154B 151B 6,478B EV / Sales 2017
6.33x
EV / Sales 2018 14.7x
Free-Float
81.91%
Yield 2017 *
-
Yield 2018 -
1 day+0.07%
1 week-3.59%
Current month+0.99%
1 month-6.54%
3 months+9.29%
6 months-20.56%
Current year-37.68%
1 week 1,512
Extreme 1512
1,599
1 month 1,512
Extreme 1512
1,680
Current year 1,201
Extreme 1201
2,795
1 year 1,201
Extreme 1201
2,795
3 years 1,201
Extreme 1201
7,180
5 years 1,201
Extreme 1201
12,950
10 years 1,201
Extreme 1201
35,500
Manager TitleAgeSince
Chief Executive Officer 66 2014-04-10
Chief Tech/Sci/R&D Officer 58 -
Comptroller/Controller/Auditor 59 -
Director TitleAgeSince
Director/Board Member 66 2014-04-10
Director/Board Member 58 2014-04-10
Director/Board Member 59 2014-04-10
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-3.59%-42.91%-49.34% 22.88M
+4.16%+3.04%+49.37%+94.17% 74.41B
-3.11%-3.53%+21.92%+74.60% 59.26B
+0.89%-0.63%+4.28%+34.51% 47.14B
+0.36%+0.81%+352.17%+689.61% 44.13B
-0.96%-4.50%+26.36%+33.18% 42.91B
-0.20%-0.77%+3.74%+100.60% 40.79B
-0.54%+2.93%+9.31%+50.41% 30.77B
-2.68%+2.92%+29.63%+19.50% 29.31B
+0.05%-1.64%-7.28%-14.06% 24.33B
Average -0.20%-0.66%+44.66%+103.32% 39.31B
Weighted average by Cap. +0.10%-0.73%+58.45%+129.22%

Financials

2017 2018
Net sales 5.19B 6,989B 4.61B 4.3B 3.92B 7.4B 499B 7.47B 52.08B 20.18B 255B 19.48B 19.06B 818B 4.73B 6,377B 4.21B 3.93B 3.58B 6.75B 455B 6.81B 47.52B 18.41B 233B 17.78B 17.39B 747B
Net income -1.47B -1,979B -1.31B -1.22B -1.11B -2.1B -141B -2.11B -14.75B -5.72B -72.23B -5.52B -5.4B -232B -3.11B -4,184B -2.76B -2.58B -2.35B -4.43B -299B -4.47B -31.18B -12.08B -153B -11.66B -11.41B -490B
Net Debt -3.55B -4,784B -3.16B -2.95B -2.68B -5.06B -341B -5.11B -35.65B -13.81B -175B -13.34B -13.05B -560B 1.93B 2,604B 1.72B 1.6B 1.46B 2.76B 186B 2.78B 19.41B 7.52B 95.04B 7.26B 7.1B 305B
Logo GeneMatrix Inc.
Genematrix Inc is a Korea-based company primarily engaged in the development and sale of medical diagnostic reagents. The Company mainly offers molecular diagnostic products and biochemical diagnostic reagents. The molecular diagnostic product includes the Neoplex detection kit, used to identify sexually transmitted infections, human papillomavirus infections, respiratory infections, tuberculosis and gastrointestinal infections. The biochemical diagnostic reagent includes the HiSens detection kit, used for syphilis screening. In addition, the Company is involved in the distribution of medical equipment.
Employees
31
Date Price Change Volume
26-10-02 ₩1,530.00 +0.07% 11,300
26-10-01 ₩1,529.00 +0.92% 23,181
26-09-30 ₩1,515.00 -1.24% 25,802
26-09-29 ₩1,534.00 -3.28% 42,261
26-09-28 ₩1,586.00 -0.06% 23,073
  1. Stock Market
  2. Stocks
  3. A109820 Stock